Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 – 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005)
Condition(s):BacteremiaLast Updated:August 28, 2018Completed
Hide Studies Not Open or Pending
Condition(s):BacteremiaLast Updated:August 28, 2018Completed
Condition(s):MRSA BacteremiaLast Updated:May 30, 2017Completed
Condition(s):EndophthalmitisLast Updated:May 11, 2023Recruiting
Condition(s):PneumoniaLast Updated:September 1, 2017Completed
Condition(s):Communicable Diseases; Infection; Anti-Infective Agents; Therapeutic Uses; Pharmacologic ActionsLast Updated:April 4, 2022Completed
Condition(s):Staphylococcus Aureus InfectionsLast Updated:February 13, 2018Withdrawn
Condition(s):Overweight and ObesityLast Updated:January 19, 2024Not yet recruiting
Condition(s):Critical Illness; Augmented Renal ClearanceLast Updated:May 17, 2019Unknown status
Condition(s):Arthropathy of Knee; Antibiotic ProphylaxisLast Updated:March 25, 2024Recruiting
Condition(s):Infection; PneumoniaLast Updated:February 17, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.